Original REO Speedwagon members will reunite for a special one-night-only benefit concert. The announcement came through Bruce Hall’s Facebook page. Former frontman Kevin Cronin will not participate in the event, which takes place in Bruce Hall’s hometown to benefit cancer research.
“So excited for this ONE night only event, back where it all began, in MY hometown! Looking forward to reminiscing, rockin’ with the founding fathers and saying a proper goodbye,” Hall stated. “Most importantly, this celebration benefits the REO Speedwagon Foundation for rare GU cancer research at Moffitt Cancer Center. I truly believe Gary is proud and smiling down on us. Let’s Rock!”
The band announced the end of their touring career last year. Kevin Cronin now performs REO Speedwagon songs with his own group, separate from this reunion event.
The upcoming benefit concert carries special meaning due to the band’s rich history and recent lineup changes.
Band Origins
Documentation from The Saturday Evening Post reveals REO Speedwagon’s formation in Champaign, Illinois in 1967. The band developed their signature sound in this location.
The band drew inspiration for their name from the REO Speed Wagon. Founding member Neal Doughty discovered this 1915 truck, designed by Ransom E. Olds, during a History of Transportation class.
Commercial Success
Historical records from documented sources highlight the band’s peak success in the 1980s. Their album ‘Hi Infidelity’ became a milestone release, achieving sales of over ten million copies.
This achievement solidified REO Speedwagon’s status as a defining rock band of the era. Their success included multiple platinum records and consistently sold-out tours.
Recent Developments
The band’s decision to end their touring career closes a chapter spanning more than five decades of live performances.
Kevin Cronin performs the band’s catalog with his own group. This special reunion gathering offers original members a unique opportunity to unite for a worthy cause. They will honor their legacy while supporting cancer research.
